The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Increased Plasminogen Activator Inhibitor Type 1 in Coronary Artery Atherectomy Specimens From Type 2 Diabetic Compared With Nondiabetic Patients: A Potential Factor Predisposing to Thrombosis and Its Persistence
Open accessAbstract
Background —Inhibition of fibrinolysis attributable to elevated concentrations of plasminogen activator inhibitor type 1 (PAI-1) in blood is associated with insulin resistance, hyperinsulinemia, and type 2 diabetes mellitus. Because we have shown that insulin can stimulate PAI-1 synthesis in vivo and because accelerated vascular disease is common in such patients as well, we hypothesized that increased PAI-1, potentially predisposing to thrombosis, acute occlusion, and accelerating atherosclerosis because of thrombus-associated mitogens, would be present in excess in atheroma from type 2 diabetic subjects. Methods and Results —Samples acquired by directional coronary atherectomy from 25 patients with type 2 diabetes and 18 patients without diabetes were characterized qualitatively histologically for cellularity and by immunohistochemistry visually and qualitatively and by quantitative image analysis for assessment of urokinase-type plasminogen activator (u-PA) and PAI-1. Patients with and without diabetes were similar with respect to demographic features and the distribution and severity of coronary artery disease. Substantially more PAI-1 and substantially less u-PA were present in the atherectomy samples from subjects with diabetes. Conclusions —The disproportionate elevation of PAI-1 compared with u-PA observed in atheromatous material extracted from vessels of diabetic subjects is consistent with increased gene expression of PAI-1 in vessels as well as the known increase of PAI-1 in blood, presumably reflecting increased synthesis. The increased PAI-1 detected in the atheroma may contribute in vivo to accelerated or persistent thrombosis underlying acute occlusion and to vasculopathy exacerbated by clot-associated mitogens in the vessel wall. Because the changes were observed to be associated with insulin resistance and type 2 diabetes mellitus, they may be modifiable by reduction of insulin resistance with insulin sensitizers and stringent control of hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4069 · Cited by 461
Self-citationVague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M. C., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
Kannel, W. B., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., & Gagnon, D. R. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90026-t · Cited by 368
Insulin Resistance, Glucose Intolerance and Hyperinsulinemia in Patients with Hypertension
Swislocki, A. L. M., Hoffman, B. B., & Reaven, G. M. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.6.419 · Cited by 316
Factors Responsible for Impaired Fibrinolysis in Obese Subjects and NIDDM Patients
McGill, J. B., Schneider, D. J., Arfken, C. L., Lucore, C. L., & Sobel, B. E. (1994) · Diabetes · doi:10.2337/diab.43.1.104 · Cited by 310
Self-citationSamad, F., Yamamoto, K., & Loskutoff, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118404 · Cited by 301
Juhan-Vague, I., Roul, C., Alessi, M. C., Ardissone, J. P., Heim, M., & Vague, P. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646598 · Cited by 289
Vantrimpont, P., Rouleau, J. L., Wun, C.-C., Ciampi, A., Klein, M., Sussex, B., Arnold, J. M. O., Moyé, L., & Pfeffer, M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00489-5 · Cited by 274
Tissue Distribution and Regulation of Plasminogen Activator Inhibitor-1 in Obese Mice
Samad, F., & Loskutoff, D. J. (1996) · Molecular Medicine · doi:10.1007/bf03401641 · Cited by 188
Induction of Plasminogen Activator Inhibitor Type-1 (PAI-1) by Proinsulin and Insulin In Vivo
Nordt, T. K., Sawa, H., Fujii, S., & Sobel, B. E. (1995) · Circulation · doi:10.1161/01.cir.91.3.764 · Cited by 185
Self-citationSchneider, D. J., & Sobel, B. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9959 · Cited by 161
Self-citationNordt, T. K., Schneider, D. J., & Sobel, B. E. (1994) · Circulation · doi:10.1161/01.cir.89.1.321 · Cited by 159
Self-citationEhrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199801000-00017 · Cited by 129
Self-citationInsulin secretion, insulin resistance, and obesity.
DeFronzo, R. A. (1982) · PubMed · Cited by 116
Jain, S. K., Nagi, D. K., Slavin, B. M., Lumb, P. J., & Yudkin, J. S. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb01992.x · Cited by 115
Calles-Escandón, J., Ballor, D. L., Harvey‐Berino, J., Ades, P. A., Tracy, R. P., & Sobel, B. E. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.1.7 · Cited by 80
Self-citationHlatky, M. A. (1997) · JAMA · Cited by 77
Schneider, D. J., & Sobel, B. E. (1996) · Coronary Artery Disease · doi:10.1097/00019501-199611000-00004 · Cited by 63
Self-citationChanges in Arterial Expression of Fibrinolytic System Proteins in Atherogenesis
Schneider, D. J., Ricci, M. A., Taatjes, D. J., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3294 · Cited by 60
Self-citationPotentiation of Vasculopathy by Insulin: Implications From an NHLBI Clinical Alert
Sobel, B. E. (1996) · Circulation · doi:10.1161/01.cir.93.9.1613 · Cited by 52
Self-citationIncreased proliferation of explanted vascular smooth muscle cells: a marker presaging atherogenesis
Absher, P. M., Schneider, D. J., Baldor, L. C., Russell, J. C., & Sobel, B. E. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06104-2 · Cited by 46
Self-citationSchneider, D. J., & Sobel, B. E. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200506 · Cited by 29
Self-citationAltered fibrinolysis and platelet function in the development of vascular complications of diabetes
Sobel, B. E. (1996) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199608000-00011 · Cited by 10
Self-citation
Cited by
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 806
Carr, M. E. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00132-x · Cited by 763
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Metabolism and the Circadian Clock Converge
Eckel-Mahan, K., & Sassone-Corsi, P. (2013) · Physiological Reviews · doi:10.1152/physrev.00016.2012 · Cited by 525
Metadata
- Authors
- Sobel, B. E., Woodcock-Mitchell, J., Schneider, D. J., Holt, R. E., Marutsuka, K., & Gold, H.
- Venue
- Circulation
- Published
- 1998-06-09
- Volume
- 97
- Issue
- 22
- Pages
- 2213-2221
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2032602729
- Cited by
- 271
- References
- 25
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.